Previous studies have reported that histone deacetylase (HDAC) overexpression is common in hepatitis B virus (HBV)-infected liver cancer patients (17, 18) and could lead to carcinogenesis, as HDACs regulate the deacetylation of histone and non-histone proteins, thereby coordinating gene expression or protein activation. The gene discussed is HDAC9; the disease is liver cancer.